The cytotoxic effect against EGFR-overexpressing cancer cells was improved upon dual display of TRAIL and EGFRAfb on the AaLS (AaLS/TRAIL/EGFRAfb) compared with that of AaLS/TRAIL both in vitro and in vivo. Here, TNFSF10 is linked to cancer.